A Study of Minirin Melt in Patients With Nocturia

Retrospective Safety Study in 12 Months Treatment Nocturia With Minirin Melt in Clinical Practice in Czech Republic

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01212224

Enrollment

2187

Registered

2010-09-30

Start date

2010-01-31

Completion date

2013-12-31

Last updated

2014-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nocturia

Brief summary

This is a confirmation of safety profile for Minirin Melt in clinical practice.

Interventions

None listed

Study design

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 64 Years

Healthy volunteers

Inclusion criteria

* nocturia

Exclusion criteria

* habitual or psychogenic polydipsia * known or suspected cardiac insufficiency and other conditions requiring treatment with diuretics * moderate and severe renal insufficiency * know hyponatremia * syndrome of inappropriate ADH secretion

Design outcomes

Primary

Measure	Time frame
Verify the safety profile	12 months

Secondary

Measure	Time frame
Safety aspect of dosage	12 months

Countries

Czechia

Outcome results